Clinical Trial Perspective: Cost-effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation. Results From the COAPT Trial
Treatment of secondary (or functional) mitral regurgitation had traditionally been limited to optimal medical therapy because studies have failed to show a survival benefit with mitral valve surgery for this condition. However, recently the Cardiovascular Outcomes Assessment of the MitraClip Percuta...
Saved in:
| Main Author: | Suzanne J Baron |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2020-08-01
|
| Series: | US Cardiology Review |
| Online Access: | https://www.uscjournal.com/articles/clinical-trial-perspective-cost-effectiveness |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of Secondary Mitral Regurgitation in Heart Failure: A Shifting Paradigm in the Wake of the COAPT Trial
by: Kelly H Schlendorf, et al.
Published: (2020-07-01) -
Transcatheter edge-to-edge mitral valve repair <i>versus</i> medical therapy for secondary mitral regurgitation: a meta-analysis of randomized controlled trials
by: Emídio Mata, et al.
Published: (2025-02-01) -
Transcatheter mitral valve edge-to-edge repair in patients with severe mitral regurgitation: data from the MitraClip Russia Trial
by: T. E. Imaev, et al.
Published: (2022-03-01) -
First-in-human Results of the Novel Transcatheter Mitral Valve Repair System for Severe Mitral Regurgitation
by: Zhi-Nan Lu, et al.
Published: (2024-06-01) -
Functional Mitral Regurgitation and the Role of Transcatheter Repair
by: Richa Gupta, MD, MPH, et al.
Published: (2025-07-01)